✦ LIBER ✦

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial

✍ Scribed by C. Lai; C. Ching; A. K. Tung; E. Li; J. Young; A. Hill; B. C. Wong; J. Dent; P. Wu

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 162 KB
Volume: 25
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510250144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The absence of hepatitis B virus DNA in

The absence of hepatitis B virus DNA in hepatitis B e antigen positive sera from chronic hepatitis B surface antigen carriers in China

✍ Janet S. Scott; Pei-En Pan; Raymond A. Pace; Theo P. Sloots; Prof. W. Graham Coo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

## Abstract Sera from 20 Chinese patients with chronic hepatitis B were examined for hepatitis B e antigen and hepatitis B virus (HBV) DNA. There was considerable discordance with HBV DNA not being detectable in 10 out of 13 (77%) patients who were hepatitis B e antigen positive. Further testing fo

A unique insertion in the S gene of surf

A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers

✍ Jinlin Hou; Peter Karayiannis; Jenny Waters; Kangxian Luo; Chishen Liang; Howard 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

δ Infection in asymptomatic carriers of

δ Infection in asymptomatic carriers of hepatitis B surface antigen: Low prevalence of δ activity and effective suppression of hepatitis B virus replication

✍ Pei-Jer Chen; Ding-Shinn Chen; Chiou-Rong Chen; Yu-Ying Chen; Hsu-Mei Hsu Chen; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission

A randomized, controlled trial of a 24-m

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

✍ P Lampertico; E Del Ninno; A Manzin; M F Donato; M G Rumi; G Lunghi; A Morabito; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 3 views

## Short-term interferon treatment of serum hepatitis B e anti- Chronic infection with precore mutant strains of hepatitis B virus (HBV) resulting in infection with hepatitis B surface gen (HBeAg)-negative carriers with serum hepatitis B virus (HBV) DNA and histological features of chronic hepatit

Reduced hepatitis B virus surface antige

Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the Trimera mouse

✍ Wulf Otto Böcher; Eithan Galun; Hadar Marcus; Nili Daudi; Dov Terkieltaub; Danie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views